Switching, Selection and Sustainability of Basal Insulin Formulations: Focus on Individualized Indications for Converting Among Basal Insulin Formulations and Improving Regimen Adherence and Safety Through Improved Devices, Formulations, and Delivery Systems for Insulin Vivian A. Fonseca, MD, FRCP - Program Chair